Impact of CytoSorb® on interleukin-6 in cardiac surgery

OBJECTIVE: Cardiac surgery is known to activate a cascade of inflammatory mediators leading to a systemic inflammatory response. Hemadsorption (HA) devices such as CytoSorb® have been postulated to mitigate an overshooting immune response, which is associated with increased morbidity and mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisler, Daniela, Arleth, Noemi, Grabenwöger, Johannes, Arnold, Zsuzsanna, Aschacher, Thomas, Winkler, Bernhard, Mach, Markus, Grabenwöger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498300/
https://www.ncbi.nlm.nih.gov/pubmed/37711559
http://dx.doi.org/10.3389/fcvm.2023.1166093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498300/
https://www.ncbi.nlm.nih.gov/pubmed/37711559
http://dx.doi.org/10.3389/fcvm.2023.1166093

Ejemplares similares